002022 科华生物
交易中 05-28 10:32:57
资讯
新帖
简况
科华生物:公司及控股子公司天隆公司有埃博拉病毒检测相关科研产品
证券之星 · 05-27 15:42
科华生物:公司及控股子公司天隆公司有埃博拉病毒检测相关科研产品
科华生物:公司及控股子公司天隆公司有埃博拉病毒检测相关科研产品
证券之星 · 05-27 15:42
科华生物:公司及控股子公司天隆公司有埃博拉病毒检测相关科研产品
股市必读:科华生物(002022)5月21日收盘跌5.09%,主力净流出707.28万元
证券之星 · 05-22
股市必读:科华生物(002022)5月21日收盘跌5.09%,主力净流出707.28万元
恒瑞医药与BMS刷新合作纪录;默沙东与多家药企签署协议
21世纪经济报道 · 05-13
恒瑞医药与BMS刷新合作纪录;默沙东与多家药企签署协议
科华生物最新公告:控股子公司全自动核酸分析系统获医疗器械注册证
证券之星 · 05-12
科华生物最新公告:控股子公司全自动核酸分析系统获医疗器械注册证
科华生物:公司控股子公司天隆公司有汉坦病毒检测试剂盒
证券之星 · 05-12
科华生物:公司控股子公司天隆公司有汉坦病毒检测试剂盒
科华生物最新公告:获得高密度脂蛋白3胆固醇测定试剂盒医疗器械注册证
证券之星 · 05-11
科华生物最新公告:获得高密度脂蛋白3胆固醇测定试剂盒医疗器械注册证
科华生物(002022.SZ):“全自动化学发光免疫分析仪”获得医疗器械注册证
智通财经 · 05-06
科华生物(002022.SZ):“全自动化学发光免疫分析仪”获得医疗器械注册证
每周股票复盘:科华生物(002022)一季度净亏4845万
证券之星 · 05-03
每周股票复盘:科华生物(002022)一季度净亏4845万
科华生物:公司实际控制人与公司自然人股东彭家钰无关联关系
证券之星 · 04-30
科华生物:公司实际控制人与公司自然人股东彭家钰无关联关系
股市必读:科华生物一季报 - 第一季度单季净利润同比增长9.03%
证券之星 · 04-29
股市必读:科华生物一季报 - 第一季度单季净利润同比增长9.03%
图解科华生物一季报:第一季度单季净利润同比增长9.03%
证券之星 · 04-28
图解科华生物一季报:第一季度单季净利润同比增长9.03%
科华生物:集采及区域检测中心建设项目
证券之星 · 04-21
科华生物:集采及区域检测中心建设项目
科华生物:计提信用减值损失、资产减值损失和折旧与摊销虽然会减少净利润,但不会有现金流出
证券之星 · 04-21
科华生物:计提信用减值损失、资产减值损失和折旧与摊销虽然会减少净利润,但不会有现金流出
科华生物(002022)披露2025年年度审计报告,4月20日股价上涨1.39%
证券之星 · 04-20
科华生物(002022)披露2025年年度审计报告,4月20日股价上涨1.39%
科华生物(002022)披露2025年年度报告,4月17日股价下跌2.05%
中金财经 · 04-17
科华生物(002022)披露2025年年度报告,4月17日股价下跌2.05%
科华生物(002022)3月31日股东户数4.83万户,较上期增加7.12%
证券之星 · 04-17
科华生物(002022)3月31日股东户数4.83万户,较上期增加7.12%
科华生物最新公告:2025年净亏损7.32亿元
证券之星 · 04-16
科华生物最新公告:2025年净亏损7.32亿元
科华生物最新公告:两款产品获得医疗器械注册证
证券之星 · 04-10
科华生物最新公告:两款产品获得医疗器械注册证
股市必读:科华生物(002022)4月3日董秘有最新回复
证券之星 · 04-07
股市必读:科华生物(002022)4月3日董秘有最新回复
加载更多
公司概况
公司名称:
上海科华生物工程股份有限公司
所属行业:
医药制造业
上市日期:
2004-07-21
主营业务:
上海科华生物工程股份有限公司的主营业务是体外诊断试剂、仪器的研发、生产和销售。公司的主要产品是体外诊断试剂、仪器。公司及子公司曾获得“国家科技进步二等奖”“国家高新技术企业”“国家知识产权示范企业”“国家发改委生物医学工程高技术产业化示范企业”“中国中小企业创新100强”“上海市著名商标证书”“上海名牌”“上海市科学技术奖”“上海市创新型企业”“陕西省和西安市创新型企业”“陕西省院士工作站”等荣誉,并多次入选上海百强企业多项榜单。
发行价格:
11.12
{"stockData":{"symbol":"002022","market":"SZ","secType":"STK","nameCN":"科华生物","latestPrice":5.43,"timestamp":1779935577000,"preClose":5.44,"halted":0,"volume":2410500,"delay":0,"changeRate":-0.0018,"floatShares":513999999,"shares":513999999,"eps":-1.4141,"marketStatus":"交易中","change":-0.01,"latestTime":"05-28 10:32:57","open":5.48,"high":5.5,"low":5.41,"amount":13187000,"amplitude":0.0165,"askPrice":5.44,"askSize":175,"bidPrice":5.43,"bidSize":160,"shortable":0,"etf":0,"ttmEps":-1.4141,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1779939000000},"marketStatusCode":2,"adr":0,"adjPreClose":5.44,"symbolType":"stock","openAndCloseTimeList":[[1779931800000,1779939000000],[1779944400000,1779951600000]],"highLimit":5.98,"lowLimit":4.9,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":514350669,"isCdr":false,"pbRate":1.1,"roa":"--","roe":"--","epsLYR":-1.4235,"committee":0.216809,"marketValue":2793000000,"turnoverRate":0.0047,"status":1,"floatMarketCap":2793000000},"requestUrl":"/m/hq/s/002022","defaultTab":"news","newsList":[{"id":"2638957757","title":"科华生物:公司及控股子公司天隆公司有埃博拉病毒检测相关科研产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2638957757","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638957757?lang=zh_cn&edition=full","pubTime":"2026-05-27 15:42","pubTimestamp":1779867727,"startTime":"0","endTime":"0","summary":"证券之星消息,科华生物(002022)05月26日在投资者关系平台上答复投资者关心的问题。投资者提问:近期非洲地区埃博拉疫情出现波动,请问公司目前是否具备埃博拉病毒相关检测设备、检测试剂产品,相关产品技术储备及市场应用情况如何?科华生物回复:尊敬的投资者,您好!公司及控股子公司天隆公司有埃博拉病毒检测相关科研产品,但目前仅供科研使用。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052700026330.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002022","BK0046","BK0239","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638577502","title":"科华生物:公司及控股子公司天隆公司有埃博拉病毒检测相关科研产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2638577502","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638577502?lang=zh_cn&edition=full","pubTime":"2026-05-27 15:42","pubTimestamp":1779867727,"startTime":"0","endTime":"0","summary":"证券之星消息,科华生物(002022)05月26日在投资者关系平台上答复投资者关心的问题。投资者提问:请问贵司有埃博拉病毒检测吗?科华生物回复:尊敬的投资者,您好!公司及控股子公司天隆公司有埃博拉病毒检测相关科研产品,但目前仅供科研使用。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052700026331.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","002022","BK0239","BK0046","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637735914","title":"股市必读:科华生物(002022)5月21日收盘跌5.09%,主力净流出707.28万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2637735914","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637735914?lang=zh_cn&edition=full","pubTime":"2026-05-22 03:12","pubTimestamp":1779390732,"startTime":"0","endTime":"0","summary":"截至2026年5月21日收盘,科华生物报收于5.59元,下跌5.09%,换手率2.03%,成交量10.44万手,成交额6015.67万元。来自交易信息汇总:前10个交易日主力资金累计净流入280.55万元,期间股价累计下跌6.24%。交易信息汇总股价提醒5月21日科华生物收盘报5.59元,跌5.09%,当日成交1043.9万元。资金流向5月21日主力资金净流出707.28万元,占总成交额11.76%;游资资金净流入11.16万元,占总成交额0.19%;散户资金净流入696.12万元,占总成交额11.57%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200003540.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0046","002022","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635221419","title":"恒瑞医药与BMS刷新合作纪录;默沙东与多家药企签署协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2635221419","media":"21世纪经济报道","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635221419?lang=zh_cn&edition=full","pubTime":"2026-05-13 08:02","pubTimestamp":1778630577,"startTime":"0","endTime":"0","summary":"政策动向国家药监局局长黄果会见新加坡卫生科学局局长蔡瑞文双方就创新医疗器械等议题深入交换意见国家药监局局长黄果5月11日在京会见了来访的新加坡卫生科学局局长蔡瑞文一行,并签署《中华人民共和国国家药品监督管理局与新加坡共和国卫生科学局监管合作谅解备忘录》。双方就细胞和基因治疗、创新医疗器械及人工智能产品监管等议题深入交换意见。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605133735150673.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"d8fdac8d3d9097cb034fb43ab6bd5883","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605133735150673.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SGXZ57979304.SGD","LU2097828474.EUR","LU0203345920.USD","LU2125154935.USD","LU1037948897.HKD","301206","LU1116320737.USD","LU1064130708.USD","LU2097828714.EUR","LU2495084118.USD","LU0859254822.USD","LU1655091616.SGD","LU1066051225.USD","LU2360032135.SGD","LU2361044865.SGD","LU0359201885.HKD","SG9999001440.SGD","LU1820825898.SGD","BK0196","002022","BK0183","LU1941712264.USD","LU1989771016.USD","LU0405327494.USD","LU1974910355.USD","BK4550","BK0060","LU1066051498.USD","LU2289578879.USD","LU2357627491.SGD","BK4588","LU0058720904.USD","LU1934455863.HKD","LU0289739699.SGD","IE00BBT3K403.USD","IE0002141913.USD","LU1934455277.USD","LU1069347547.HKD","LU1037948541.HKD","SG9999001176.USD","LU0320765646.SGD","BK0012","IE00B1BXHZ80.USD","BK4533","LU0265550359.USD","LU1066051811.HKD","LU1291159041.SGD","BK4559","LU1035773651.USD","BK0028","BK0239","600276","SG9999002224.SGD","LU0861579265.USD","IE00BSNM7G36.USD","LU0266013472.USD","LU1997245094.SGD","LU0203347892.USD","LU2491050154.USD","LU2580892862.HKD","IE0009355771.USD","LU2125154778.USD","LU0208291251.USD","LU1989772923.USD","LU1934455194.USD","LU0432979614.USD","LU0868494617.USD","LU1093756168.USD","LU0238689110.USD","LU1162221912.USD","LU0265550946.USD","LU2023250504.SGD","LU1571399168.USD","LU1328615791.USD","SG9999014542.SGD","LU0965508806.USD","LU1917777945.USD","LU2097828631.EUR","LU1116320901.HKD","IE00BJT1NW94.SGD","LU1061106388.HKD","LU2491049909.HKD","LU1699723380.USD","LU0965509101.SGD","LU0130517989.USD","LU1430594728.SGD","LU2089984988.USD","LU1585245621.USD","IE000M9KFDE8.USD","SG9999014575.USD","LU1057294990.SGD","IE00B4R5TH58.HKD","LU2097828805.USD","LU0359202008.SGD","LU0648001328.SGD","LU2112291526.USD","BK4585","LU1969619763.USD","LU1929549753.HKD","LU2468319806.SGD","LU1023059063.AUD","LU0070302665.USD","LU2361044949.HKD","IE00B2B36J28.USD","688506","SG9999002232.USD","LU1989772840.SGD","LU0405327148.USD","LU0098860793.USD","LU1941712348.USD","LU1983299246.USD","SG9999014567.USD","BK4534","LU0942090050.USD","MRK","LU1093756325.SGD","LU1146622755.USD","IE00BN8TJ469.HKD","LU0985320562.USD","BK1191","LU0320765489.SGD","SG9999015341.SGD","BK4007","LU2023250843.SGD","LU0130102774.USD","IE00BFTCPJ56.SGD","01276","LU0965509010.AUD","LU1255011170.USD","LU1023057109.AUD","LU1997244956.HKD","SG9999001176.SGD","LU2106854487.HKD","IE00BLSP4239.USD","LU0359201612.USD","LU2328871848.SGD","IE00BJJMRZ35.SGD","LU0477156953.USD","LU0234572021.USD","LU1066053197.SGD","LU1781817850.SGD","LU2580892789.USD","LU2461242641.AUD","LU2097828557.USD","LU0006306889.USD","LU0106261372.USD","LU1201861249.SGD","LU2361045086.USD","LU0122379950.USD","LU0980610538.SGD","SG9999015358.SGD","LU0965509283.SGD","LU2543165471.USD","SG9999014559.SGD","LU1997245177.USD","LU2491050071.SGD","SG9999013999.USD","BK0188","LU2148510915.USD","LU2488822045.USD","LU2324357040.USD","LU1064131003.USD","IE00BLSP4452.SGD","LU1580142542.USD","BK4516","LU0211331839.USD","LU0868494708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634291214","title":"科华生物最新公告:控股子公司全自动核酸分析系统获医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2634291214","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634291214?lang=zh_cn&edition=full","pubTime":"2026-05-12 17:18","pubTimestamp":1778577532,"startTime":"0","endTime":"0","summary":"科华生物(002022.SZ)公告称,公司控股子公司西安天隆科技的全自动核酸纯化及扩增检测分析系统获得国家药监局颁发的医疗器械注册证,有效期至2031年5月10日。该产品基于磁珠法核酸提取和实时荧光PCR检测原理,用于人体样本中靶核酸的定性、定量检测,包括病原体和人类基因检测项目。此次注册证取得将丰富公司产品线,对业务发展有正面影响,但具体营收影响尚无法预测。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051200029255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0188","BK0239","BK0028","09996","002022","BK1574","BK1583","159883","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634268441","title":"科华生物:公司控股子公司天隆公司有汉坦病毒检测试剂盒","url":"https://stock-news.laohu8.com/highlight/detail?id=2634268441","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634268441?lang=zh_cn&edition=full","pubTime":"2026-05-12 11:33","pubTimestamp":1778556827,"startTime":"0","endTime":"0","summary":"证券之星消息,科华生物(002022)05月11日在投资者关系平台上答复投资者关心的问题。投资者提问:汉坦病毒爆发,请问公司及子公司有此病毒的检测试剂吗?科华生物回复:尊敬的投资者,您好!公司控股子公司天隆公司有汉坦病毒检测试剂盒,目前销售占比极小,未对公司合并报表营业收入产生重大影响。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051200016671.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","002022","BK0046","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634407522","title":"科华生物最新公告:获得高密度脂蛋白3胆固醇测定试剂盒医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2634407522","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634407522?lang=zh_cn&edition=full","pubTime":"2026-05-11 18:01","pubTimestamp":1778493665,"startTime":"0","endTime":"0","summary":"科华生物(002022.SZ)公告称,公司近日收到上海市药品监督管理局颁发的医疗器械注册证,产品为高密度脂蛋白3胆固醇测定试剂盒(过氧化物酶法),注册证有效期至2031年5月6日。该产品用于体外定量测定人血清、血浆样本中高密度脂蛋白3胆固醇的浓度。此次注册证的取得丰富了公司产品线,将对公司业务发展产生正面影响,但公司尚无法预测对营业收入的具体影响,请投资者注意投资风险。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100025420.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002022","BK0188","BK0046","BK1100","BK1574","159883","BK0239","09996","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633900450","title":"科华生物(002022.SZ):“全自动化学发光免疫分析仪”获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2633900450","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633900450?lang=zh_cn&edition=full","pubTime":"2026-05-06 16:51","pubTimestamp":1778057463,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科华生物(002022.SZ)发布公告,近日,公司全资子公司科华(西安)生物工程有限公司收到陕西省药品监督管理局颁发的医疗器械注册证。涉及产品:“全自动化学发光免疫分析仪”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438538.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1574","BK0046","002022","BK1100","BK1222","BK0239","BK0188","BK0028","09996","159883","09997"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632608672","title":"每周股票复盘:科华生物(002022)一季度净亏4845万","url":"https://stock-news.laohu8.com/highlight/detail?id=2632608672","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632608672?lang=zh_cn&edition=full","pubTime":"2026-05-03 08:15","pubTimestamp":1777767318,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,科华生物报收于5.97元,较上周的5.77元上涨3.47%。本周,科华生物4月29日盘中最高价报6.03元。科华生物当前最新总市值30.71亿元,在医疗器械板块市值排名111/129,在两市A股市值排名4611/5200。本周关注点来自业绩披露要点:科华生物2026年一季报显示,归母净利润-4845.13万元,同比上升9.03%。股本股东变化股东户数变动截至2026年3月31日,科华生物股东户数为4.83万户,较2025年12月31日增加3214户,增幅7.12%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300002035.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002022","BK0046","BK0188","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631688763","title":"科华生物:公司实际控制人与公司自然人股东彭家钰无关联关系","url":"https://stock-news.laohu8.com/highlight/detail?id=2631688763","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631688763?lang=zh_cn&edition=full","pubTime":"2026-04-30 15:42","pubTimestamp":1777534930,"startTime":"0","endTime":"0","summary":"证券之星消息,科华生物(002022)04月29日在投资者关系平台上答复投资者关心的问题。投资者提问:请问贵公司年报股东彭家钰和实控人什么关系?科华生物回复:尊敬的投资者,您好!公司实际控制人与公司自然人股东彭家钰无关联关系。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000047985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0188","002022","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631305405","title":"股市必读:科华生物一季报 - 第一季度单季净利润同比增长9.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631305405","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631305405?lang=zh_cn&edition=full","pubTime":"2026-04-29 07:26","pubTimestamp":1777418780,"startTime":"0","endTime":"0","summary":"来自业绩披露要点:科华生物2026年一季度归母净利润为-4845.13万元,同比上升9.03%。股本股东变化股东户数变动近日科华生物披露,截至2026年3月31日公司股东户数为4.83万户,较12月31日增加3214.0户,增幅为7.12%。业绩披露要点财务报告科华生物2026年一季报显示,一季度公司主营收入3.95亿元,同比上升1.86%;归母净利润-4845.13万元,同比上升9.03%;扣非净利润-5138.4万元,同比上升9.27%;负债率32.9%,投资收益169.83万元,财务费用885.24万元,毛利率36.81%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900021696.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630489603","title":"图解科华生物一季报:第一季度单季净利润同比增长9.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630489603","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630489603?lang=zh_cn&edition=full","pubTime":"2026-04-28 05:12","pubTimestamp":1777324336,"startTime":"0","endTime":"0","summary":"证券之星消息,科华生物2026年一季报显示,一季度公司主营收入3.95亿元,同比上升1.86%;归母净利润-4845.13万元,同比上升9.03%;扣非净利润-5138.4万元,同比上升9.27%;负债率32.9%,投资收益169.83万元,财务费用885.24万元,毛利率36.81%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800013703.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629709555","title":"科华生物:集采及区域检测中心建设项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2629709555","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629709555?lang=zh_cn&edition=full","pubTime":"2026-04-21 11:33","pubTimestamp":1776742386,"startTime":"0","endTime":"0","summary":"证券之星消息,科华生物04月20日在投资者关系平台上答复投资者关心的问题。公司公开发行可转换公司债券的募投项目“集采及区域检测中心建设项目”“化学发光生产线建设项目(调整)”在实施过程中,受市场环境变化、行业发展变化等多方面因素的影响,建设进度较预计有所延缓,无法在计划时间内达到预定可使用状态。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100024514.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0046","002022","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629709598","title":"科华生物:计提信用减值损失、资产减值损失和折旧与摊销虽然会减少净利润,但不会有现金流出","url":"https://stock-news.laohu8.com/highlight/detail?id=2629709598","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629709598?lang=zh_cn&edition=full","pubTime":"2026-04-21 11:33","pubTimestamp":1776742385,"startTime":"0","endTime":"0","summary":"2、经营活动产生的现金净流量与本年度净利润的差异原因主要为:计提信用减值损失、资产减值损失和折旧与摊销虽然会减少净利润,但不会有现金流出;递延所得税资产冲回会减少净利润,但不会有现金流出;经营性应收款项的减少,表明收到以前年度货款,影响现金流量,但不影响净利润。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100024510.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002022","159399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628746045","title":"科华生物(002022)披露2025年年度审计报告,4月20日股价上涨1.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628746045","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628746045?lang=zh_cn&edition=full","pubTime":"2026-04-20 17:42","pubTimestamp":1776678149,"startTime":"0","endTime":"0","summary":"截至2026年4月20日收盘,科华生物报收于5.82元,较前一交易日上涨1.39%,最新总市值为29.94亿元。近日,科华生物发布2025年年度审计报告。公告显示,容诚会计师事务所对上海科华生物工程股份有限公司2025年度财务报表进行了审计,出具了标准无保留意见的审计报告。审计报告显示,科华生物2025年12月31日的合并及母公司财务状况,以及2025年度的经营成果和现金流量在所有重大方面按照企业会计准则的规定编制,公允反映了公司的财务状况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000024854.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002022","BK0046","BK0028","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628277632","title":"科华生物(002022)披露2025年年度报告,4月17日股价下跌2.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628277632","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628277632?lang=zh_cn&edition=full","pubTime":"2026-04-17 18:02","pubTimestamp":1776420136,"startTime":"0","endTime":"0","summary":"h2,h3,h4{padding: 10px 0;font-size: 16px;line-height: 30px;color:#262626;font-weight: 600;}h2{border-bottom: 1px solid #d8dee4; padding-bottom: 0.3em}.article_content ul{padding-left:22px;}截至2026年4月17日收盘,科华生物报收于5.74元,较前一交易日下跌2.05%,最新总市值为29.52亿元。该股当日开盘5.84元,最高5.85元,最低5.63元,成交额达6652.52万元,换手率为2.26%。公司于2026年4月17日披露《2025年年度报告》。报告显示,科华生物2025年末总资产为4,641,435,221.85元,归属于上市公司股东的净资产为2,637,914,841.01元,较上年末分别减少11.36%和21.25%。经营活动产生的现金流量净额为22,438,665.38元,同比增长144.77%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260417/32152056.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["002022","BK0046","BK0239","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628304274","title":"科华生物(002022)3月31日股东户数4.83万户,较上期增加7.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628304274","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628304274?lang=zh_cn&edition=full","pubTime":"2026-04-17 17:12","pubTimestamp":1776417170,"startTime":"0","endTime":"0","summary":"证券之星消息,近日科华生物披露,截至2026年3月31日公司股东户数为4.83万户,较12月31日增加3214.0户,增幅为7.12%。在医疗器械行业个股中,科华生物股东户数高于行业平均水平,截至3月31日,医疗器械行业平均股东户数为2.2万户。从股价来看,2025年12月31日至2026年3月31日,科华生物区间跌幅为1.01%,在此期间股东户数增加3214.0户,增幅为7.12%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041700032330.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0046","BK0188","002022","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627218749","title":"科华生物最新公告:2025年净亏损7.32亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2627218749","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627218749?lang=zh_cn&edition=full","pubTime":"2026-04-16 20:30","pubTimestamp":1776342604,"startTime":"0","endTime":"0","summary":"科华生物(002022.SZ)公告称,公司发布2025年年度报告摘要,实现营业收入16.42亿元,同比下降6.63%;归属于上市公司股东的净利润为-7.32亿元。公司计划不派发现金红利,不送红股,不以公积金转增股本。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600040193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","002022","BK0028","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626556196","title":"科华生物最新公告:两款产品获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2626556196","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626556196?lang=zh_cn&edition=full","pubTime":"2026-04-10 17:50","pubTimestamp":1775814655,"startTime":"0","endTime":"0","summary":"科华生物(002022.SZ)公告称,公司及控股子公司苏州天隆近日分别收到国家药监局颁发的医疗器械注册证。其中,苏州天隆的“EB病毒核酸测定试剂盒(PCR-荧光探针法)”获证,用于体外定量检测人全血或血浆中的EB病毒DNA核酸;公司的“解脲脲原体核酸检测试剂盒(PCR-荧光法)”获证,用于体外定性检测男性尿道拭子、女性宫颈拭子样本中的解脲脲原体核酸。上述注册证有效期均为5年。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041000031074.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK1222","BK1574","BK1100","002022","159883","09996","09997","BK0046","BK0188","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625601636","title":"股市必读:科华生物(002022)4月3日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2625601636","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625601636?lang=zh_cn&edition=full","pubTime":"2026-04-07 04:19","pubTimestamp":1775506750,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘,科华生物报收于5.81元,下跌2.68%,换手率1.48%,成交量7.6万手,成交额4434.07万元。董秘最新回复投资者: 请问珠海保联投资控股有限公司近三年有没有减持计划?除此之外,近三年珠海保联持股未发生变化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700002561.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","002022","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779935578268,"stockEarnings":[{"period":"1week","weight":-0.0764},{"period":"1month","weight":-0.0764},{"period":"3month","weight":-0.114},{"period":"6month","weight":-0.1893},{"period":"1year","weight":-0.0963},{"period":"ytd","weight":-0.0842}],"compareEarnings":[{"period":"1week","weight":-0.0164},{"period":"1month","weight":0.0018},{"period":"3month","weight":-0.0128},{"period":"6month","weight":0.0528},{"period":"1year","weight":0.2254},{"period":"ytd","weight":0.0315}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海科华生物工程股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"48349人(较上一季度减少68.74%)","perCapita":"10636股","listingDate":"2004-07-21","address":"上海市徐汇区钦州北路1189号","registeredCapital":"51435万元","survey":" 上海科华生物工程股份有限公司的主营业务是体外诊断试剂、仪器的研发、生产和销售。公司的主要产品是体外诊断试剂、仪器。公司及子公司曾获得“国家科技进步二等奖”“国家高新技术企业”“国家知识产权示范企业”“国家发改委生物医学工程高技术产业化示范企业”“中国中小企业创新100强”“上海市著名商标证书”“上海名牌”“上海市科学技术奖”“上海市创新型企业”“陕西省和西安市创新型企业”“陕西省院士工作站”等荣誉,并多次入选上海百强企业多项榜单。","listedPrice":11.12},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科华生物(002022)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科华生物(002022)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科华生物,002022,科华生物股票,科华生物股票老虎,科华生物股票老虎国际,科华生物行情,科华生物股票行情,科华生物股价,科华生物股市,科华生物股票价格,科华生物股票交易,科华生物股票购买,科华生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科华生物(002022)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科华生物(002022)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}